The effect of two different doses of vecuronium on the heart rate and mean arterial pressure response to tracheal intubation was compared in 32 adult ASA class I patients. It was found that the higher dose of vecuronium (2.5 X ED9:J produced greater depression of the evoked electromyogram (P < 0.01), and provided better intubating conditions (P < 0.01) than the lower dose of vecuronium (1 X ED9:J. However, the heart rate and the mean arterial pressure response to tracheal intubation was similar with both doses. The results indicate that, within the range of neuromuscular blockade commonly used to facilitate tracheal intubation, the depth of neuromuscular blockade per se does not affect the haemodynamic response to intubation.
Although neuromuscular blocking drugs are widely used to facilitate tracheal intubation, it is not known whether the depth of neuromuscular blockade affects the haemodynamic response to intubation. Nevertheless, it has been postulated that neuromuscular blockade 'deepens' the level of anaesthesia by paralysing peripheral muscle spindles, thereby reducing afferent input to the reticular activating system. I ,2 If this is so, it is possible that increasing the depth of neuromuscular blockade does reduce the haemodynamic response to intubation, because it is well known that deepening the level of anaesthesia obtunds the haemodynamic response to intubation and other noxious stimuli. 3 ,4 However, the hypothesis that 'the depth of neuromuscular blockade affects the haemodynamic response to intubation' has not been tested previously.
Vecuronium is a nondepolarising neuromuscular blocking drug which is often used to facilitate tracheal intubation. 5 Vecuronium can be used in a wide range of doses without producing significant cardiovascular side-effects. 5 -7 These features make vecuronium an ideal drug with which to study the effects of neuromuscular blockade on haemodynamic responses. The aim of the current study was to examine the effect of two different doses of vecuronium on the heart rate (HR) and mean arterial pressure (MAP) response to laryngoscopy and tracheal intubation in humans.
MATERIALS AND METHODS
After Human Rights Committee approval and informed consent were obtained, 32 adult ASA Class 1 patients scheduled for elective surgery were studied. Inclusion critera required the planned use of tracheal intubation and an estimated duration of surgery of at least sixty minutes. Patients who had abnormal upper airway anatomy, a risk of oesophageal reflux, or who were greater than 20% above ideal body weight were excluded. Randomisation and blinding: Patients were randomised into two equal groups. Group 1 received vecuronium (VEC) 0.05 mg.kg -I IV (1 X ED 95 ) for intubation, and group 2 received VEC 0.125 mg.kg -I IV (2.5 X ED95)' The groups to which the patients were assigned were indicated in sealed identical envelopes. One envelope was chosen at random for each patient. Two anaesthetists were involved in the care of each study patient. The anaesthetist performing the laryngoscopy and intubation was blinded to the group to which the patient had been assigned. On each occasion this was one of the investigators. Monitoring: Monitoring consisted of continuous electrocardiography (ECG) (Roche lOS, Digital Electronics, Watford, England), pulse oximetry, and oscillometric automatic blood pressure measurement (Dinamap ™ lS46SX, Critikon Inc, Tampa, USA). The mean arterial pressure (MAP) was measured approximately every 20 seconds using the Dinamap in 'stat' mode. The MAP and the heart rate (HR) were recorded on a Dinamap printer (TR2000, Critikon Inc, Tampa, USA). Each HR reading was checked against the digital HR display of the ECG monitor. The end-tidal carbon dioxide tension (ETC0 2 ) was continuously monitored using a Datex CDlOl monitor (Datex Instrumentation, Helsinki, Finland). Neuromuscular blockade was assessed by measuring the evoked electromyogram (EMG) of the abductor digiti minimi following transcutaneous stimulation of the ulnar nerve (Monash Neuromuscular Block Monitor, Electro-Med, Armadale, Australia).8 The control response was obtained immediately after the induction of anaesthesia, but before the administration of vecuronium. The evoked EMG (% control) at the time of intubation was recorded for each patient. Anaesthetic technique: The anaesthetic technique was similar in both groups. Anaesthetic premedication consisted of oral temazepam 20 mg one hour before surgery. Induction was achieved with midazolam 0.02 mg.kg -1 and fentanyl 2 Ilg.kg -1 given by IV bolus, followed by thiopentone 5 mg.kg-1 IV over 15 seconds. The vecuronium was administered by IV bolus immediately after the induction of anaesthesia and the calibration of the EMG monitor. The patient's lungs were then ventilated with 66% N 20 in O 2 for three minutes before intubation. ETC0 2 was maintained in the normal range (35-40 mmHg). Only patients who were intubated within 30 seconds of commencing laryngoscopy were included in the study. Therefore, the interval between the induction of anaesthesia and the intubation of the trachea was similar in all patients. No other drugs were administered until at least two minutes after intubation. Intubation conditions were scored using criteria modified from Fahey et af.9 (0 = vocal cords abducted, no cough; 1 = vocal cords abducted, slight cough; 2 = vocal cords slightly abducted, cough; 3 = vocal cords fully adducted). Statistical analysis: The pre-induction HR and MAP were defined as the minimum values in the one minute prior to the induction of anaesthesia. The pre-intubation HR and MAP were defined as the values just prior to commencing laryngoscopy. The post-intubation HR and MAP were defined as the maximum values in the first two minutes after commencing laryngoscopy. The pre-induction, preintubation, and postintubation values in group 1 were compared with the values in group 2 using two-tailed t tests. Similarly, the maximum changes in HR and MAP in response to tracheal intubation (post-intubation minus pre-intubation) in group 1 were compared with the values in group 2. Demographic variables (age, weight) and the evoked EMG at the time of intubation were also compared between the groups using two-tailed t tests. The intubation scores were compared using a two-tailed Mann-Whitney U test. In all cases, P values < 0.05 were considered significant.
RESULTS
There was no significant difference between the two groups with regard to either age or weight. The mean age in group 1 was 34.9 (2.S) years (SEM in parenthesis) and in group 2 was 40.2 (2.9) years. The mean weight in group 1 was 61.6 (2.7) kg and in group 2 was 66.5 (3.3) kg. All patients were intubated within thirty seconds of commencing laryngoscopy. Table 1 gives the evoked EMG, the intubation scores, and the maximum changes in HR and MAP in response to intubation, for both group 1 and group 2. The mean evoked EMG (% control) in group 1 was higher than group 2 (P < 0.01). The mean intubation score in group 1 was higher than group 2 (P< 0.01). There was no significant difference in the maximum changes in HR or MAP in response to intubation between the two groups. Table 2 gives the mean pre-induction, preintubation, and post-intubation HR and MAP values for both groups. There was no significant Heart rate (HR) and Mean arterial pressure (MAP) values are mean with SEM in parenthesis. P values obtained using two-tailed t tests.
difference in the mean pre-induction or postintubation HR or MAP. However, the preintubation MAP in group 2 was slightly higher than in group 1 (P= 0.04).
DISCUSSION
Tracheal intubation is a potent noxious stimulus which provokes a major haemodynamic response in most patients. There has been extensive research into measures to reduce this response. 13 However, there have been no previous studies on the effect of the depth of neuromuscular blockade on this response. Nevertheless, the effect of neuromuscular blockade should not be ignored, because neuromuscular blocking drugs are frequently employed to facilitate tracheal intubation, and the depth of neuromuscular blockade can often be altered by adjusting the dose of the neuromuscular blocking drug used.
Our results demonstrate that increasing the depth of neuromuscular blockade from 53% depression of the evoked EMG (mean ± SEM) to 95% depression of the evoked EMG does not reduce either the HR or the MAP response to tracheal intubation. As such, our results suggest that the depth of neuromuscular blockade does not affect the haemodynamic response to intubation. However, our results apply only to the range of neuromuscular blockade observed in this study and we can make no inferences on the effect of neuromuscular blockade outside this range. Nevertheless, the observed range represents the range of neuromuscular blockade commonly employed to facilitate tracheal intubation in clinical practice, because less than 50% depression of the evoked EMG risks inadequate paralysis for intubation and 95% depression of the evoked EMG is close to maximal neuromuscular blockade.
If succinylcholine is used to facilitate tracheal intubation, neuromuscular blockade is usually rapid and complete. 7 However, if a nondepolarising neuromuscular blocking drug such as vecuronium is used, the depth of neuromuscular blockade depends on many factors such as the dose of the drug used,5,6 the interval between its administration and intubation,5-7 and the presence or absence of a 'priming' dose. 14 If succinylcholine is contraindicated, a nondepolarising neuromuscular blocking drug can be used to facilitate rapid-sequence intubation. 5 -7 However, even large doses of non depolarising neuromuscular blocking drugs (with or without a priming dose) cannot provide maximal neuromuscular blockade as rapidly as succinylcholine. 7 Therefore, in the interests of rapid airway protection, tracheal intubation may occasionally be performed before the onset of complete neuromuscular blockade. This is one situation in which it is important to know whether the absence of complete neuromuscular blockade has any adverse effect on the haemodynamic response to intubation. Our results suggest that incomplete neuromuscular blockade per se does not adversely affect the haemodynamic response to intubation.
Vecuronium was used in the current study because it has no direct cardiovascular effects when used in clinical doses. 5,6 Therefore it is unlikely that the different doses of vecuronium had a direct effect on haemodynamic variables. However, the pre-intubation MAP in group 2 was higher than in group 1 (P = 0.04, Table 2 ). There was no associated difference in the pre-intubation HR ( Table 2) . We have no explanation for the observed difference in the pre-intubation MAP. It is possible that this observation represents a type I error. We made multiple simultaneous comparisons between the groups which increases the chances of making a type I error. 15 Indeed, it is often appropriate to reduce a when multiple simultaneous comparions are made. 15 If we made this correction, a would be < 0.01 and the observed difference in the preintubation MAP would not be statistically significant.
We used a noninvasive method to measure MAP and our study may be criticised in this regard. Nevertheless, we were mostly interested in trend information and several studies have shown that the Dinamap provides satisfactory trend information in healthy patients. I 6-17 Moreover, we studied a large number of patients and we Anaesthesia and Intensive Care. Vol. 19. No. I. February. 1991 anticipated that any minor inaccuracies would be similarly distributed in each group. Similarly we did not require continuous monitoring of MAP because the changes induced by tracheal intubation are not evanescent, and tend to be sustained for at least 60 seconds.lo,11 As such, the MAP monitoring technique we employed was sensitive enough for the purposes of the study.
In the interpretation of our results it is important to note that our results apply primarily to the effects of non depolarising neuromuscular blockade produced by vecuronium and do not necessarily apply to the effects of other neuromuscular blocking drugs. Indeed, it has been shown that alcuronium reduces the MAP response to tracheal intubation in humans. 18 However, our results suggest that if other neuromuscular blocking drugs reduce the haemodynamic response to intubation, it is likely that it is through a mechanism independent of neuromuscular blockade.
In conclusion, our results indicate that, within the range of neuromuscular blockade commonly used to facilitate tracheal intubation, the depth of neuromuscular blockade per se does not affect the haemodynamic response to tracheal intubation. We recommend using a dose of neuromuscular blocking drug which will provide maximal neuromuscular blockade and optimal intubating conditions whenever possible. However, if maximal neuromuscular blockade is not achieved, our results suggest that incomplete neuromuscular blockade per se will not adversely affect the haemodynamic response to intubation,
